Ensidipine Patient Medication Guide

Enasidenib is an oral targeted inhibitor mainly used to treat specific types of acute myeloid leukemia (AML), patients with Patients with newly diagnosed, refractory, or relapsedAML mutations in >IDH2 (isocitrate dehydrogenase2). For patients using ensidipine, the following is a Patient Medication Guide designed to provide important information and advice before, during, and after use.

Before taking medication:

1.Clinical Evaluation: Before starting treatment with ensidipine, your doctor will conduct a thorough clinical evaluation, including a history, physical examination, and examination to ensure that you are suitable for treatment with this drug.

2.Understand treatment goals: Before starting treatment, discuss treatment goals and expected results with your doctor. Learn about ensidipine's mechanism of action and possible therapeutic effects, as well as possible side effects and risks.

3.Understand the medication guidelines: Carefully read the ensidipine package insert and patient information leaflet to understand the correct method, dosage, frequency, and possible adverse reactions and precautions.

During medication:

1.Take the medicine as directed by your doctor: Take ensidipine strictly according to the doctor's instructions and the recommendations in the drug package insert, including dosage, frequency and taking time.

2.Regular follow-up visits: During the treatment process, regular follow-up visits are very important. Your doctor will perform regular checkups to evaluate the effectiveness and safety of your treatment and adjust your treatment plan as needed.

3.Monitor adverse reactions: Pay attention to observe whether adverse reactions or side effects occur during medication, such as digestive system discomfort, abnormal liver function, etc. Report any symptoms of discomfort to your doctor promptly.

4.Drug interactions: During medication, avoid using it with other drugs, supplements or herbs at the same time to avoid drug interactions. Before starting treatment with ensidipine, be sure to tell your doctor about all the medicines you are taking.

After taking medication:

1.Continuous monitoring: Even after treatment ends, your doctor may ask you to continue regular follow-up visits and monitoring. This helps assess the duration of response and any potential risk of recurrence.

2.Lifestyle and Nutrition: Maintaining a healthy lifestyle and eating habits during and after treatment is very important for your body's recovery and health. Follow the advice of your doctor and nutritionist to maintain proper diet and exercise habits.

3.Follow your doctor’s advice: It is very important to follow your doctor’s advice and instructions during and after medication. If you have any questions or concerns, please communicate with your doctor promptly.

Ensidipine is an important drug in the treatmentAML, but its use requires close collaboration between patient and physician. Following correct medication guidelines, promptly reporting any symptoms of discomfort to your doctor, and conducting regular follow-up visits and monitoring will help ensure the efficacy and safety of your treatment. Maintaining good communication with your doctor and actively participating in the treatment process is one of the key steps to effectively deal with AML.